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Abstract In adults with heart failure, central sleep apnea
(CSA), often manifested as Cheyne–Stokes respiration, is
common, and has been associated with adverse outcome.
Heart failure in children is commonly caused by dilated
cardiomyopathy (DCM). It is unknown whether children
with heart failure secondary to DCM have CSA, and whe-
ther CSA is related to the severity of heart failure. In this
prospective observational study, 37 patients (\18 year)
with heart failure secondary to DCM were included. They
underwent polysomnography, clinical and laboratory eval-
uation and echocardiographic assessment. After a median
follow-up time of 2 years, eight patients underwent heart
transplantation. CSA (apnea–hypopnea index [AHI] C1)
was found in 19 % of the patients. AHI ranged from 1.2 to
4.5/h. The occurrence of CSA was not related to the severity
of heart failure. Three older patients showed a breathing
pattern mimicking Cheyne–Stokes respiration, two of
whom required heart transplantation. CSA was found in
19 % of the children with heart failure secondary to DCM.
No relation was found with the severity of heart failure. In a
small subset of children with severe DCM, a pattern mim-
icking Cheyne–Stokes respiration was registered.
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Introduction
In adults with heart failure, central sleep apnea (CSA) is
highly prevalent [1–4]. Cheyne–Stokes respiration is a
form of CSA and, in adults with heart failure, used as a
synonym for CSA [5]. The occurrence of CSA in adults
with heart failure is associated with the severity of heart
failure and with higher mortality rates [1, 2, 6, 7].
Dilated cardiomyopathy (DCM) in children is a severe
cardiac disorder resulting in heart failure. To the best of our
knowledge, so far, no study has been published that has
investigated whether CSA occurs in children with heart
failure. According to the prevalence in adults, we specu-
lated that CSA occurs in children with heart failure and
may also be related to the severity of heart failure.
Therefore, we conducted a prospective study to determine
the prevalence of CSA and its clinical relevance in children
with heart failure secondary to DCM.
Methods
Patient Selection
Between October 2010 and October 2013, children
(\18 year) with DCM were asked to participate in a nation-
wide prospective follow-up study. DCM was defined as a left
ventricle end-diastolic dimension (LVEDD)[95th percentile
for body surface area and a shortening fraction (SF) B25 %.
DCM was of idiopathic origin or secondary to other causes.
Patients with DCM secondary to neuromuscular diseases
were excluded, because sleep-disordered breathing can be
present as result of muscular weakness [8, 9].
As part of the follow-up study, an overnight
polysomnography was planned. Furthermore, a detailed
clinical evaluation, including echocardiography, NT-pro
BNP measurement and clinical assessment using the New
York University Pediatric Heart Failure Index [10], was
performed within 3 months of the polysomnography.
Medication use and demographic data (age, gender and
duration of DCM) were recorded. Follow-up data were
collected through January 2015. Primary end points were
death and heart transplantation. The review board of all
participating centers approved the protocol. All parents,
and patients C12 year, gave their written informed consent.
Sleep Study
Patients underwent overnight polysomnography either at
home or in hospital. Measurements at home were done with
the Embletta Portable Diagnostic System and analyzed
using Somnologica for Embletta Software 3.3 ENU
(Medcare Flage, Reykjavik, Iceland). Embletta is a multi-
channel test that continuously measures respiration by a
pressure transducer attached to a nasal cannula (Salter labs,
Arvin USA), breathing effort through respiratory elastic
belts at abdominal and chest level (X act), and oxygen
saturation (SaO2) and heart rate using an infant or pediatric
oxygen sensor (OxiMax; Nellcor, Pleasanton, USA) on a
fingertip. Caregivers were instructed to apply all sensors
and to start the measurement at bedtime and to end the
measurement the next morning. In hospital, measurements
were performed using BrainRT Shell ? (OSG BVBA,
Rumst, Belgium) and analyzed using BrainRT
Shell ? (version 1.0, Patch Pack 5, build 2570). Oronasal
flow was measured with a thermal sensor. Breathing effort
was measured through respiratory elastic belts at abdomi-
nal and chest level, heart rate using three electrocardiogram
leads and SaO2 using an infant or pediatric oxygen sensor
on a fingertip (OxiMax; Nellcor, Pleasanton, USA) applied
to a pulse oxymeter (Xpod, Nonin Medical). Recordings of
both devices were analyzed using the same methods as
described below.
Due to the absence of electroencephalography, arousals
were not recorded and therefore not used in the criteria. In
some patients, one of the channels (SaO2, nasal flow or
impedance) showed a technical failure. Measurements
were excluded if either the impedance or the SaO2 was
missing, because the purpose of the study was to detect
central apneas. Mean pulse rate and mean respiratory rate
were labeled as, respectively, tachycardia and tachypnea if
they were[90th percentile for age [11].
Scoring Respiratory Events
One observer (SvdB), blinded to the clinical characteristics
of the patients, scored the sleep studies. All respiratory
events were scored according to the American Academy of
Sleep Medicine (AASM) criteria [12]. An apnea was
defined as a drop in peak signal excursions of C90 %.
Central apnea was scored if inspiratory effort was absent
throughout the entire duration of the event and one of the
following criteria were met: (1) the event lasted C20 s; (2)
the event lasted for at least 2 breaths and was accompanied
by an oxygen desaturation of C3 %. A central apnea fol-
lowing a sigh was scored only if it caused a desaturation
C3 %. Hypopnea was defined as a reduction of C30 % of
the pre-events baseline flow, lasted for at least 2 breaths
and was accompanied by a desaturation of C3 %.
We calculated the apnea–hypopnea index (AHI) as the
number of central apneas and hypopneas per hour of sleep.
An AHI of C1 was defined as abnormal [13–17]. Periodic
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breathing was scored if C3 episodes of central apnea lasted
[3 s separated by no more than 20 s of normal breathing.
Statistical Analysis
All continuous variables are displayed as median (IQR),
because of the low sample size in this study. Categorical
variables are displayed as numbers and percentages. Dif-
ference between the median of two independent groups
were assessed using the Mann–Whitney U test. Relation-
ships between two non-normally distributed continuous
variables were assessed using Spearman’s correlation.
Statistical significance was defined as p\ 0.05.
Results
Study Group
During the 3 years of the follow-up study, 58 of 79 eligible
patients were willing to undergo polysomnography. Of
these 58, eight patients were not measured, because they
died or received a heart transplantation shortly after
inclusion and before the polysomnography was performed;
and in 13 patients the measurement failed, due to a lack of
patient cooperation. As a result, 37 measurements were
available.
The median age of the patients was 11.1 years. The
median time since diagnosis of DCM was 3.6 years (range
0–15.6 years). Almost all patients (97 %) took angiotensin-
converting enzyme inhibitors, 81 % took b-blockers and
70 % took diuretics as medical treatment for heart failure.
The median LVEDD z-score was ?4.7 and SF 19.4 %.
(Table 1)
The 34 patients in whom polysomnography was not per-
formed (n = 21 not willing to undergo polysomnography
and n = 13 measurement failure) were significantly younger
(median age 3.3 years; p = 0.007) than the study group. LV
dilation and function was not significantly different between
groups (LVEDD z-score ?5.8 [IQR 3.2-9.2], p = 0.3, and
SF 16.8 % [IQR 11.9–19.8], p = 0.08).
Sleep Study
Thirty-three patients (89 %) were measured at home with
the ambulatory device, whereas four patients were mea-
sured in hospital. The median recording time was 513 min.
Five recordings were shorter than 360 min (range
211–352). As we studied the prevalence of sleep-disor-
dered breathing, we included these measurements in the
analysis.
Of 37 patients, seven (19 %) had AHI C1 (range
1.2–4.5). These children were significantly younger than
children with AHI \1 (median age 2.9 vs 12.3 year,
p = 0.01). Three patients were younger than one year of
age; all had an abnormal AHI (C1) (Table 2).
In three patients, clusters of apneas and hypopneas were
noticed at the end of the night. The first patient (age
12 years) had a typical crescendo–decrescendo cycling
pattern in breathing amplitude with apneas and hypopneas
with a maximal episode duration of 58 min (Fig. 1). Only
one apnea led to an oxygen desaturation, resulting in an
AHI of only 0.1. The breathing pattern appeared as
Cheyne–Stokes respiration and the duration of the episodes
counted for 14.5 % of the total registration time (Table 3).
The second patient (age 16 years) had several apneas
[20 s with and without oxygen desaturations, reflected as
an AHI of 2.6. The cycling pattern appeared as both
Cheyne–Stokes and as periodic breathing and accounted
for 27 % of the total registration time. The third patient
(age 15 years) had a mild cycling breathing pattern without
desaturations and a maximum duration of almost 17 min
per episode (AHI 0). This breathing pattern appeared as
periodic breathing and counted for 0.5 % of the total reg-
istration time.
Heart Failure Severity and Follow-up
During the measurement, tachycardia was present in two
patients and tachypnea in nine patients.
The AHI was not correlated with the severity of heart
failure symptoms, expressed as NYU PHFI, and also not
with the severity of LV dysfunction and dilation (SF and
LVEDD z-score), and not with the time since DCM diag-
nosis. During follow-up (median 2.0 years, IQR 1.3–3.2),
eight patients underwent heart transplantation, no deaths
occurred. The patients who underwent heart transplantation
had more heart failure symptoms and worse LV function
than those who survived without transplantation. AHI was
not different between groups (Tables 1 and 2).
Discussion
In this prospective observational study, we assessed the
prevalence of CSA in children with heart failure and DCM.
In 19 % of the children, we detected CSA, defined as AHI
[1. We found no relation between the occurrence of CSA
and the severity of heart failure in children. Three older
patients showed episodes of a cycling pattern of cres-
cendo–decrescendo changes in breathing amplitude with
apneas and hypopneas, according to pediatric criteria
defined as periodic breathing and mimicking Cheyne–
Stokes respiration.
The prevalence of CSA in children with heart failure
was lower than in adults with heart failure. We found an
250 Pediatr Cardiol (2016) 37:248–254
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increased number of central sleep apneas and hypopneas in
seven children (19 %), while reports in adults showed a
prevalence of CSA around 35–40 % [1, 2, 4]. CSA in
children was defined as AHI C1/h, while in adults CSA is
defined as mild if AHI C5, moderate if AHI 15–29 and
severe if AHI C30 [18]. Thus, as compared to adults with
mean values reported around 30/h [1, 2, 4], the severity of
CSA in children seemed relatively mild. Since the preva-
lence of CSA was low, we were not able to relate CSA to
outcome.
Cheyne–Stokes respiration is a typical breathing
abnormality, which is seen in adults with heart failure and
associated with higher mortality rates [19]. In the current
manual for scoring respiratory events in children, no rules
Table 1 Patient characteristics and clinical data within 3 months of the polysomnography
All patients (n = 37) No end point (n = 29) Heart transplantation (n = 8) p value
Male, n (%) 19 (51)
Age (year) 11.1 (3.3–15.5) 8.7 (2.5–15.5) 12.3 (6.2–15.2) NS
Etiology of DCM, n (%)
Idiopathic 26 (70)
Myocarditis 3 (8)
Othera 8 (22)
Time since diagnosis of DCM (year) 3.6 (1.6–7.6)
Medication use, n (%)
Diuretics 26 (70) 18 (62) 8 (100) 0.04
ACEi 36 (97) 29 (100) 7 (88) NS
ß-blockers 30 (81) 22 (76) 8 (100) NS
NYU PHFI 8 (5–11) 8 (4–10) 13 (10–14) 0.004
NT-pro BNP (pmol/L) 132 (79–480) 96 (50–195) 502 (417–776) 0.001
LVEDD z-score ?4.7 (3.3–6.9) ?4.1 (3.1–6.1) ?6.3 (3.7–9.3) NS
SF (%) 19.4 (13.6–26.1) 19.7 (15.8–26.6) 12.2 (5.9–19.6) 0.01
Categorical variables are displayed as number (%), continuous variables are displayed as median (IQR)
DCM dilated cardiomyopathy, ACEi angiotensin-converting enzyme inhibitor, NYU PHFI New York University Pediatric Heart Failure Index,
range 0–30, NT-pro BNP N-terminal B-type natriuretic peptide, LVEDD left ventricular end-diastolic dimension, SF shortening fraction
a Category ‘other’ includes four patients with familial or genetic disease, three patients with prior use of anthracycline and one patient with
vasculitis
Table 2 Polysomnography results
All patients (n = 37) No end point (n = 29) Heart transplantation (n = 8) p value
Total registration time (min) 513 (481–576)
Resting heart rate (bpm) 78 (62–97)
Tachycardia, n (%) 2 (5)
Respiratory rate (/min) 21 (18–24)
Tachypnea, n (%) 9 (24)
Mean O2-saturation (%) 98 (97–98)
Minimal O2-saturation (%) 91 (88–94)
Mean O2-desaturation (%) 4.4 (3.9–5.2)
AHI (/h) 0.2 (0.05–0.55) 0.2 (0–0.5) 0.44 (0.13–1.01) NS
0–1/h, number of patients (%) 30 (81) 24 (83) 6 (75) NS
1–5/h, number of patients (%) 7 (19) 5 (17) 2 (25)
C5/h, number of patients (%) 0 (0)
Categorical variables are displayed as number (%), continuous variables are displayed as median (IQR). AHI apnea–hypopnea index, tachycardia
and tachypnea defined as[90th percentile of the reference values [11]
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for Cheyne–Stokes breathing are listed. However, scoring
rules for periodic breathing are described for children and
these mimic the rules for Cheyne–Stokes respiration [12].
Indeed, in three children a typical pattern of periodic
breathing and Cheyne–Stokes respiration was detected. All
were older children, respectively, 12, 15 and 16 years old.
The two patients with the most severe manifestation of
Cheyne–Stokes respiration had both severe DCM: both
underwent transplantation, respectively, 14 and 22 months
after the polysomnography; the third patient with mild
periodic breathing is doing well on heart failure
medication.
There may be several explanations why CSA in children
with heart failure is less prevalent than in adults. One of the
pathophysiological concepts of CSA is that the nocturnal
fluid shift from legs to lungs stimulates pulmonary irritant
chemoreceptors by pulmonary congestion, leading to
hyperventilation and subsequently to a drop in PaCO2
below the apneic threshold. The amount of fluid that
shifted from the legs was directly related to the amount of
leg edema and sitting time, and inversely related to phys-
ical activity [20]. Leg edema has been associated with the
presence of varicose veins and older age [21]. In contrast,
fluid retention in children with heart failure is commonly
associated with hepatomegaly, less often with ascites, but
rarely with leg edema. These differences may be related to
lower hydrostatic venous pressure in the legs and with
more physical activity in children as compared to adults.
Thus, the magnitude of the fluid shift may be smaller in
children preventing the occurrence of CSA.
Another factor to take into consideration may be a dif-
ference in regulation of respiration in response to CO2. One
of the mechanisms that results in a drop in PaCO2, leading
to a central apnea, is hyperventilation initiated by an
arousal [22]. Since the frequency of arousals increases with
age [23, 24], children may have a lower number of arousals
and subsequently a lower prevalence of CSA. Furthermore,
in adults with heart failure an increased sensitivity to CO2
has been observed, and the sensitivity to CO2 has been
positively correlated to the AHI [25]. In children, it is
unknown whether such changes in the ventilatory response
to CO2 exist and contribute to the occurrence of CSA.
Interestingly, Cheyne–Stokes breathing pattern in our study
was observed in the oldest children with severe heart
Fig. 1 Recording of patient one (Table 3) showing a crescendo–decrescendo cycling pattern of the breathing amplitude with apneas
Table 3 Three patients with patterns of hypopneas and apneas
Patient 1 Patient 2 Patient 3
Age (year) 12.0 15.9 15.4
Number of apneas 34 95 1
AHI (/h of sleep) 0.1 2.6 0
Crescendo/decrescendo patterns
Number 3 16 4
Minimal duration (mm:ss) 08:38 02:30 04:42
Maximal duration (mm:ss) 58:17 35:33 16:42
% of total sleep time 14.5 26.6 0.5
AHI apnea–hypopnea index
252 Pediatr Cardiol (2016) 37:248–254
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failure. One may speculate that it occurs in those with
severe heart failure and most resembling adults.
In our study, we reported the NYU PHFI to grade the
severity of heart failure. We could not detect a correlation
between NYU PHFI, LV function and dilation and the
presence of CSA. The Cheyne–Stokes breathing pattern in
two of eight children receiving a heart transplantation
indicates that there might be a relation between the severity
of heart failure and CSA, which needs further exploration.
This study has several limitations, which may have led to
an underestimation or overestimation of the prevalence of
CSA. Firstly, we recognize that we were unable to measure
a substantial number of patients due to technical and prac-
tical problems. Although we used ambulatory devices,
several parents and children were not willing to agree to
undergo polysomnography. And probably, the use of
ambulatory devices negatively influenced the success rate
of the measurements. The children who were not measured
were significantly younger, and their LV function was
similar to children who were measured. Since the midterm
prognosis of heart failure in young children is better than in
older children [26], and we found more severe breathing
abnormalities in older children, this may lower the impact
of missing these children in this study. Secondly, eight
children could not undergo a polysomnography because
they either died or underwent heart transplantation before
they could be studied. As in adults the prevalence increases
with decreasing LV function, CSA may have been missed
because we could not study this severely ill subgroup.
Thirdly, in our cohort, three of the seven patients with AHI
[1 were younger than 1 year of age. Particularly in young
infants, central sleep apneas may be the result of immature
breathing, rather than the result of heart failure [27]. The
young age of the patients may have overestimated the
prevalence. Fourthly, we included five recordings shorter
than 360 min. Regardless of total registration duration,
every central apnea was important to acknowledge calcu-
lating the prevalence. However, such short measurements
without apneas did not guarantee that these patients were
free from sleep apnea, and therefore may have led to an
underestimation of the prevalence. Finally, as already
mentioned, electroencephalography was not recorded.
Therefore, the total sleep time may have been overesti-
mated, and central apneas and hypopneas associated with
arousals, rather than with desaturation, were not scored.
This may have led to an underestimation of the AHI.
In the present study, only a relatively small patient group
remained for final analysis. In order to increase the number of
eligible patients in future research, we suggest to use in-
hospital measurements on all newly diagnosed patients, since
almost 80 % of the patients with DCM need hospital admis-
sion at diagnosis [26]. The use of in-hospital measurements
may reduce the occurrence of technical failure. Furthermore,
DCM symptoms may be worse during first admission, what
may be therefore lead to a higher detection rate of CSA.
In conclusion, in this first prospective study to investi-
gate the prevalence of central sleep apnea in children with
moderate-to-severe heart failure, we found CSA in 19 % of
the patients. In a small subset of older children with signs
of severe heart failure, a Cheyne–Stokes respiration pattern
was noticed, similar to that has been observed in adults. For
the whole study group, no relation was found with the
severity of heart failure.
All procedures performed in studies involving human
participants were in accordance with the ethical standards
of the institutional and/or national research committee and
with the 1964 Helsinki declaration and its later amend-
ments or comparable ethical standards.
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